Dyslipidemia (High Cholesterol)

What it is

Dyslipidemia is an abnormal blood lipid pattern, often with LDL cholesterol above 190 mg/dL in severe hypercholesterolemia. It is the medical term for unhealthy levels of cholesterol and/or triglycerides in the blood, including high low-density lipoprotein cholesterol (LDL-C), high triglycerides, low high-density lipoprotein cholesterol (HDL-C), or a combination of these. The main clinical concern is not the lab value by itself, but the higher risk of atherosclerotic cardiovascular disease such as heart attack and stroke. Very high triglycerides, especially above 1,000 mg/dL, also raise the risk of acute pancreatitis.

Dyslipidemia may be inherited, acquired, or both. Common acquired contributors include diabetes, hypothyroidism, obesity, kidney disease, liver disease, alcohol use, and some medicines. In India, dyslipidemia is common alongside rising rates of diabetes, central obesity, and premature cardiovascular disease, so lipid testing is often part of routine cardiometabolic risk assessment.

A simple way to think about it is:

Lipid abnormality	What it means	Why it matters
High LDL-C	Too much cholesterol carried in LDL particles	Strongly linked to plaque buildup in arteries
Low HDL-C	Lower “reverse transport” capacity	Often accompanies metabolic risk, though raising HDL alone has not clearly improved outcomes
High triglycerides	Excess circulating triglyceride-rich lipoproteins	Linked to metabolic syndrome; very high levels can trigger pancreatitis
Mixed dyslipidemia	More than one abnormality together	Common in diabetes and obesity; increases overall risk

How it works

Lipids are carried in the bloodstream by lipoproteins. LDL particles deliver cholesterol to tissues; when LDL levels stay high over time, cholesterol can enter artery walls and contribute to plaque formation. This process, called atherosclerosis, can narrow arteries or lead to plaque rupture and clot formation.

HDL helps transport cholesterol back to the liver, but HDL is more useful as a risk marker than as a direct treatment target. Triglycerides are carried mainly in chylomicrons and very-low-density lipoproteins (VLDL). High triglycerides often reflect insulin resistance, excess calorie intake, alcohol use, uncontrolled diabetes, or genetic disorders.

Dyslipidemia can be:

1. Primary (genetic): such as familial hypercholesterolemia, where LDL is markedly elevated from a young age.
2. Secondary (acquired): due to lifestyle, medical conditions, or drugs.
3. Combined: genetic susceptibility plus acquired factors, which is very common.

Secondary causes clinicians often look for include hypothyroidism, nephrotic syndrome, chronic kidney disease, cholestatic liver disease, poorly controlled diabetes, and medicines such as corticosteroids, some antiretrovirals, retinoids, and certain diuretics.

Evidence and uses

Dyslipidemia itself is usually silent, but treating it lowers cardiovascular risk. The strongest evidence is for lowering LDL-C, especially with statins. In people with established atherosclerotic cardiovascular disease, LDL lowering reduces future cardiovascular events and mortality. In primary prevention, treatment decisions depend on the overall risk profile, not just one cholesterol number.

Lifestyle treatment is the foundation for most patients:

• reducing saturated and trans fats
• increasing vegetables, fruits, legumes, nuts, and whole grains
• choosing unsaturated fats over ghee, butter, vanaspati, and fatty processed foods
• regular physical activity
• weight loss when overweight or obese
• limiting alcohol, especially if triglycerides are high
• stopping tobacco use

For many people, medicines are also needed. Common options include:

Treatment	Main effect	Typical use
Statins	Lower LDL-C and reduce cardiovascular events	First-line for most high-risk patients
Ezetimibe	Further lowers LDL-C	Added if statin alone is not enough or not tolerated
PCSK9 inhibitors	Large LDL-C reduction	Very high-risk patients or familial hypercholesterolemia
Fibrates	Lower triglycerides	Mainly for severe hypertriglyceridemia
Omega-3 fatty acid products	Lower triglycerides	Selected patients with high triglycerides

In severe hypercholesterolemia, especially LDL-C at or above 190 mg/dL, clinicians consider inherited causes such as familial hypercholesterolemia. In severe hypertriglyceridemia, the immediate goal may be pancreatitis prevention rather than long-term cardiovascular prevention.

Indian dietary counseling often focuses on reducing refined carbohydrates, deep-fried foods, bakery fats, and excess sugar, while improving intake of pulses, millets, oats, vegetables, and healthier oils. Exact diet plans should be individualized, especially for people with diabetes, kidney disease, or established heart disease.

Diagnosis / how it's measured

Diagnosis is usually made with a lipid profile. This blood test commonly includes total cholesterol, LDL-C, HDL-C, and triglycerides. Non-HDL cholesterol and apolipoprotein B may also be used in some patients, especially when triglycerides are elevated or risk is unclear.

A clinician interprets the results in context:

• age and sex
• smoking status
• blood pressure
• diabetes status
• kidney disease
• family history of early heart disease
• prior heart attack, stroke, or peripheral artery disease

Fasting is not always required for routine lipid testing, but it may be useful when triglycerides are high or when a more precise assessment is needed. If results are abnormal, repeat testing may be done to confirm the pattern and monitor response to treatment.

Clinicians may also check for secondary causes with tests such as:

• thyroid-stimulating hormone for hypothyroidism
• blood glucose or HbA1c for diabetes
• liver function tests
• kidney function tests
• urine protein in selected cases

Physical findings are uncommon but can include xanthelasma, tendon xanthomas, or corneal arcus, especially in inherited lipid disorders.

When to see a clinician

See a clinician if you have an abnormal lipid report, a strong family history of early heart disease, or relatives with very high cholesterol. You should also seek evaluation if you have diabetes, high blood pressure, obesity, chronic kidney disease, hypothyroidism, or a history of smoking, because these factors change treatment thresholds.

Urgent medical attention is needed for symptoms of heart attack or stroke, not for the cholesterol number itself. Very high triglycerides with severe upper abdominal pain, nausea, or vomiting need prompt assessment because pancreatitis can be serious.

If you are prescribed a statin or other lipid-lowering medicine, follow-up matters. Your clinician may repeat lipids after starting treatment, review side effects, and check for drug interactions or pregnancy-related precautions where relevant.

Limitations and open questions

Not all dyslipidemia carries the same risk, and a single cholesterol value does not tell the whole story. Overall cardiovascular risk, lifetime exposure to LDL, metabolic health, and inherited disorders all matter. Risk calculators are helpful but imperfect, especially in younger adults and some ethnic groups.

Evidence is strongest for LDL lowering, particularly with statins. By contrast, simply raising HDL-C has not consistently improved outcomes in trials. For triglycerides, the relationship with cardiovascular risk is more complex, and benefits depend on the patient group and the treatment used.

There is also ongoing debate about the best use of newer markers such as apolipoprotein B, lipoprotein(a), and non-HDL cholesterol in routine practice. These tests can add useful information in selected patients, but they are not needed for everyone. Management should be individualized with a clinician rather than based on one number alone.